Home/Filings/4/0001209191-18-045899
4//SEC Filing

Urso David M 4

Accession 0001209191-18-045899

CIK 0001262104other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 6:01 PM ET

Size

7.1 KB

Accession

0001209191-18-045899

Insider Transaction Report

Form 4
Period: 2018-08-06
Urso David M
Sr. V.P. and General Counsel
Transactions
  • Tax Payment

    Common Stock

    2018-08-06$3.75/sh17,764$66,61533,606 total
  • Sale

    Common Stock

    2018-08-07$3.58/sh9,500$34,04424,106 total
Footnotes (3)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018.
  • [F2]Represents the number of shares sold to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018.
  • [F3]The range of sales prices was $3.5825 to $3.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001604256

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 6:01 PM ET
Size
7.1 KB